Despite early fears of a large-scale epidemic, the monkeypox outbreak in the US has already begun to plateau. But despite the public health emergency that the Department of Health and Human Services declared on 4 August, the development of drugs and vaccines to address monkeypox differs markedly from development of countermeasures for the COVID-19 pandemic.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?